The invention relates to construction of a recombinant strain capable of producing
arginine deiminase (ADI) and a directional modification method thereof, belonging to the technical field of medical
biological engineering. The method comprises the following steps of: amplifying the ADI coding
gene arcA of a
pseudomonas plecoglossicida CGMCC (China General
Microbiological Culture Collection Center) No. 2039 by adopting a PCR (
polymerase chain reaction) method, and constructing an ADI recombination expression strain, researching the enzymology properties of the recombinant ADI
enzyme, wherein Km is 2.88mmol / L (pH is 6.0), the optimal pH is 6.0, the
enzyme activity is 20.85U / mg, and the
enzyme activity is reduced by more than 90% when the pH is increased to the physiological pH (7.4). The directional modification is carried out on the recombinant ADI enzyme by adopting a prone PCR
mutation technology, so as to improve the activity and substrate affinity of the enzyme under the physiological pH condition. An excellent
mutant strain ADIM314 is obtained by screening through the directional modification. Compared with a wild enzyme, the activity of the ADIM314 enzyme under the physiological pH condition is improved by more than 20 times, the Km value is reduced to 0.65mmol / L (pH is 7.4), and the optimal pH is improved to 6.5 from 6.0.